CN Stock MarketDetailed Quotes

300009 Anhui Anke Biotechnology

Watchlist
  • 9.47
  • -0.18-1.87%
Trading Nov 14 13:19 CST
15.88BMarket Cap20.28P/E (TTM)

Anhui Anke Biotechnology Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/H1
Stock NameRevenueRatio
Genetic engineering drug881.83M67.89%
Total special adjustments291.69M22.46%
External paste123.63M9.52%
Other business1.67M0.13%
Industry Currency:CNY
2024/H1
Stock NameRevenueRatio
Biological products901.64M69.42%
Chinese patent medicine199.03M15.32%
Chemical synthetic drugs81.36M6.26%
Raw material medicine61.05M4.70%
Total special adjustments35.28M2.72%
Technical services18.79M1.45%
Other business1.67M0.13%
View all
Region Currency:CNY
2024/H1
Stock NameRevenueRatio
华东(不含安徽)495.26M38.13%
Central and southwest China299.99M23.10%
South China174.7M13.45%
Northeast of North China153.13M11.79%
Anhui105.72M8.14%
Northwest67.47M5.19%
Other business1.67M0.13%
Total special adjustments889.49K0.07%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data